Government of Canada invests $425K into precision agriculture

Nov 25, 2016

Funding will be used to develop and commercialize the CX-6 SMART Seeder

By Diego Flammini
Assistant Editor, North American Content
Farms.com

The Canadian Government is investing $425,000 into Clean Seed Agricultural Technologies Ltd. to further develop and commercialize a piece of precision agriculture technology.

Clean Seed will use the investment to further its research into the CX-6 SMART Seeder, which can allow farmers to have simultaneous control of up to six products. The goal is to help farmers reduce over-applications of fertilizer and pesticides, while also lowering fuel usage and input costs.

The company is headquartered in Burnaby, British Columbia, but other parts of the country could benefit. Testing will take place in Saskatchewan and the machinery will be manufactured in Manitoba.

"Clean Seed Agricultural Technologies Ltd. is an innovative leader in the development of advanced precision agricultural equipment aimed at modernizing and streamlining farm operations,” Navdeep Bains, Minister of Innovation, Science and Economic Development, said in a Nov. 25 release. “The Government of Canada's investment in companies like this will generate growth in Western Canada and provide jobs for skilled workers.”

Executives with Clean Seed say the investment will help them bring the CX-6 SMART Seeder to farmers in Canada and around the world.

“The continued support by the federal government over the years has played an important role in our evolution,” Graeme Lempriere, chief executive officer of Clean Seed Capital Group Ltd. said in the release.

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.